Elon Musk Reveals Tesla’s (TSLA) Optimus Robot Could Revolutionize Surgery—Future Plans Unveiled

Elon Musk just dropped a bombshell: Tesla’s Optimus robot might soon trade wrenches for scalpels.

The Surgical Shift

Musk hinted at Optimus pivoting from auto assembly to precision medicine—think robotic surgeons with sub-millimeter accuracy. No more shaky hands or coffee breaks in the OR.

Wall Street’s Dilemma

TSLA investors now face a new calculus: should they price in robo-surgeons alongside Cybertrucks? Analysts scramble to update models while shorts pray this isn’t another ‘funding secured’ moment.

The Bottom Line

If Optimus can suture arteries better than Tesla hits production targets, hospitals might forgive Musk for that ‘electro-surgical mode’ meme. But until then—keep the defibrillators handy.

Meet Your ETF AI Analyst

• Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
• Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Tesla wants to shift from a focus on clean power to a focus on the broad use of tech in daily life. This shift sits under what Musk calls Master Plan Part IV. As a result, the firm aims to build tools that help with tasks that require tight skills.

On Friday, TSLA shares climbed a modest 0.59% to close at $404.35.

Current Stage of Optimus

Right now, the robot can only do light tasks. It can walk and lift light items. It can also pick up eggs with care. Nevertheless, Tesla wants to show a new Optimus in early 2026. The next model will have far more small parts in its hand. Tesla says this will enable the robot to make finer movements over time.

Even so, no version tailored for healthcare is in place yet. Tesla is still in the early stages of its work on this idea. The firm is also setting up lines that can build the robot at scale. It aims to make up to one million units each year once the full build starts.

Expert Views and Rules

Many health experts say this goal will take far more time. They say that robots in clinics still need a human in the room. They add that a robot must react fast if a patient has a hard turn in a case.

Rules also make this path slow. Most robots in use today fall under clear health rules. A robot that can act on its own WOULD face a higher bar. It would need deep tests that show safe use in each step. The process would take years and would need strong proof.

Experts also say that no rule set today deals with full robot use in real care. That gap makes the job even more hard. They say that each MOVE in a clinic can shift fast. A robot must deal with those shifts with care and with no risk.

What It Means for Investors

Tesla’s plan hints at a long path. The firm sees a huge new field. Yet the tech and rule steps are still far from done. As a result, this idea may take a long time to reach real use. For now, the plan shows the wide scope of Tesla’s goals. It also shows how firms seek new streams of growth as they look past Core lines in cars and power.

Is Tesla Stock a Buy, Hold, or Sell?

Tesla continues to divide opinions among the Street’s analysts with a Hold consensus rating. The average TSLA stock price target stands at $382.54, implying a 5.39% downside from the current price.